Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK

Launched by GRUPO ESPANOL DE INVESTIGACION EN SARCOMAS · Nov 26, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at the quality of care for patients with different types of sarcoma, which are cancers that can occur in soft tissues, bones, or the stomach's supportive tissues. By comparing how patients are treated at expert centers versus non-expert centers, researchers hope to understand how care quality affects important outcomes, such as how long patients live without their cancer returning and how many patients end up needing amputations. The study will also examine tumor samples to find specific markers that could help improve treatment in the future.

To participate in this trial, individuals must be at least 18 years old and have a confirmed diagnosis of soft-tissue sarcoma, gastrointestinal stromal tumors (GIST), or bone sarcoma at any time from January 2005 to June/September 2023. There are no exclusion criteria, meaning anyone who meets the age and diagnosis requirements can join. Participants can expect to provide their medical information and possibly contribute tumor samples for research purposes. The findings from this study could lead to better treatment approaches and outcomes for sarcoma patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Histological diagnosis of soft-tissue sarcoma, GIST or bone sarcoma (all subtypes) from January 2005 until Juny/September 2023.
• • ≥ 18 years
• • Available clinical and treatment information
• Exclusion Criteria:
• • There is no exclusion criteria